Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis (vol 15, pg 6, 2005)

被引：0
|
作者：
Tentolouris, N
Boutati, E
Karambakalis, N
Perrea, D
Tselepis, AD
Tsoukala, C
Kyriaki, D
Lourida, E
Anastasopoulou, I
Karafoullidou, A
Raptis, SA
Katsilambros, N
机构：
[1] Univ Athens, Laiko Hosp, Sch Med, Dept Propaedeut Med 1, Athens 11521, Greece
[2] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Propaedeut Med 2, Athens, Greece
[3] Univ Ioannina, Dept Chem, Biochem Lab, GR-45110 Ioannina, Greece
[4] Laiko Hosp, Reg Blood Transfus Ctr 2, Athens, Greece
[5] Laiko Hosp, Haemostasis Unit, Athens, Greece
来源：
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 2006年 / 16卷 / 01期
关键词：
D O I：
10.1016/j.numecd.2005.10.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [1] Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis
    Tentolouris, N
    Boutati, E
    Karambakalis, N
    Perea, D
    Tselepis, AD
    Tsoukala, C
    Kyriaki, D
    Lourida, E
    Anastasopoulou, I
    Karafoullidou, A
    Raptis, SA
    Katsilambros, N
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (01) : 6 - 12
  • [2] Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis
    Tentolouris, N
    Boutati, E
    Karamvakalis, N
    Perrea, D
    Tselepis, AD
    Tsoukala, A
    Kyriaki, D
    Tambaki, AP
    Anastasopoulou, I
    Karafoullidou, A
    Raptis, SA
    Katsilambros, N
    DIABETES, 2004, 53 : A495 - A495
  • [3] Postprandial activation of coagulation is inhibited but fibrinolysis is not altered by acute glimepiride administration in type 2 diabetic subjects.
    Ioannidis, L
    Tsoukala, C
    Markakis, K
    Anastasopoulou, I
    Xiarchopoulou, P
    Karafoulidou, A
    Maglara, E
    Katsilambros, N
    DIABETOLOGIA, 2001, 44 : A216 - A216
  • [4] Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes
    Vakkilainen, J
    Mero, N
    Schweizer, A
    Foley, JE
    Taskinen, MR
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (06) : 484 - 490
  • [5] No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes
    Johanson, EH
    Jansson, PA
    Gustafson, B
    Sandqvist, M
    Taskinen, MR
    Smith, U
    Axelsen, M
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (04) : 376 - 381
  • [6] Comparison of the acute effects of nateglinide versus glibenclamide on postprandial metabolic control in type 2 diabetes
    Dimitriadis, G
    Boutati, E
    Lambadiari, V
    Mitrou, P
    Maratou, I
    Samartzis, A
    Raptis, SA
    DIABETES, 2002, 51 : A95 - A95
  • [7] Effect of nateglinide on the postprandial triglyceride and lipoprotein concentrations in subjects at risk for type 2 diabetes
    Johanson, E
    Axelsen, M
    Jansson, PA
    Taskinen, MR
    Smith, U
    DIABETES, 2003, 52 : A211 - A211
  • [8] Comparison of the effects of nateglinide and glibenclamide on postprandial glucose and lipid fluxes in Type 2 diabetes
    Dimitriadis, G
    Boutati, E
    Lambadiari, V
    Mitrou, P
    Maratou, E
    Houssianakou, E
    Raptis, S
    DIABETOLOGIA, 2002, 45 : A245 - A245
  • [9] Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
    Toru Kato
    Teruo Inoue
    Koichi Node
    Cardiovascular Diabetology, 9
  • [10] Effects of acute administration of doxazosin on fasting and postprandial haemodynamics and lipid metabolism in healthy subjects
    Ulahannan, TJ
    Karpe, F
    Humphreys, SM
    Matthews, DR
    Frayn, KN
    HORMONE AND METABOLIC RESEARCH, 2002, 34 (09) : 499 - 503
12345